← 返回首页
亚洲 · 区域市场 · Vietnam Investment Review

Bora Pharmaceuticals reports third quarter revenue and net income growth

来源:Vietnam Investment Review · 越南 9 小时前
Bora Pharmaceuticals reports third quarter revenue and net income growth
Bora Pharmaceuticals reports third quarter revenue and net income growth · Vietnam Investment Review

详细摘要

Bora Pharmaceuticals announced third-quarter financial results on 13 November 2026 alongside operational updates confirming the completion of its manufacturing and biologics facilities in the United States.

HONG KONG SAR – Media OutReach Newswire – 13 November 2026 – Bora Pharmaceuticals ("Bora"; TWSE: 6472; OTCQX: BORAY) today announced its financial results and operational highlights for 3Q2026 and provides 2027 outlook update. 3Q26 Business and Financial Highlights

Bobby Sheng, Chairman of Bora Group, stated, "In 2026, customers are choosing Bora because we combine onshore North American capacity with capabilities rarely found in a network of our size. Our focus now is execution: completing these commercial technology transfers in our US facilities on time, qualifying our new isolator fill-finish capacity, where 4 PPQ batches have been completed and 3 additional technology transfer programs are scheduled for 2027, and delivering on every quality commitment we have made.

文章开头,摘自Vietnam Investment Review。如需阅读全文,请前往媒体网站。

在 Vietnam Investment Review 阅读全文 登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (vir.com.vn)

推荐阅读